Related Experiment Video
Updated: Apr 30, 2026

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
Published on: March 27, 2017
The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and
Timothy Pennel1, George Fercana2, Deon Bezuidenhout1
1Christian Barnard Department of Cardiothoracic Surgery, Cardiovascular Research Unit, University of Cape Town, Faculty of Health Sciences, Cape Heart Center, Chris Barnard Building, Anzio Road, ZA 7925 Observatory, Cape Town, South Africa.
Abstract:
There is a significant need for small diameter vascular grafts to be used in peripheral vascular surgery; however autologous grafts are not always available, synthetic grafts perform poorly and allografts and xenografts degenerate, dilate and calcify after implantation. We hypothesized that chemical stabilization of acellular xenogenic arteries would generate off-the-shelf grafts resistant to thrombosis, dilatation and calcification. To test this hypothesis, we decellularized porcine renal arteries, stabilized elastin with penta-galloyl glucose and collagen with carbodiimide/activated heparin and implanted them as transposition grafts in the abdominal aorta of rats as direct implants and separately as indirect, isolation-loop implants. All implants resulted in high patency and animal survival rates, ubiquitous encapsulation within a vascularized collagenous capsule, and exhibited lack of lumen thrombogenicity and no graft wall calcification. Peri-anastomotic neo-intimal tissue overgrowth was a normal occurrence in direct implants; however this reaction was circumvented in indirect implants. Notably, implantation of non-treated control scaffolds exhibited marked graft dilatation and elastin degeneration; however PGG significantly reduced elastin degradation and prevented aneurismal dilatation of vascular grafts. Overall these results point to the outstanding potential of crosslinked arterial scaffolds as small diameter vascular grafts.

